MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
NASDAQ
2.910
+0.020
+0.69%
Closed 16:46 03/28 EDT
OPEN
2.755
PREV CLOSE
2.890
HIGH
3.300
LOW
2.620
VOLUME
50.27K
TURNOVER
--
52 WEEK HIGH
7.73
52 WEEK LOW
1.770
MARKET CAP
74.59M
P/E (TTM)
-6.6031
1D
5D
1M
3M
1Y
5Y
Anebulo Pharmaceuticals Reports Positive Data from Trial of Cannabinoid Intoxication Treatment; Shares Jump
Anebulo Pharmaceuticals Reports Positive Data from Trial of Cannabinoid Intoxication Treatment; Shares Jump
MT Newswires · 1d ago
Anebulo Pharma Reports Positive Results From Phase 2 Proof Of Concept Study With ANEB-001
NASDAQ · 1d ago
Latest Executive Changes In Marijuana Industry, New Appointments & Resignations
Benzinga · 03/13 13:08
Anebulo Pharmaceuticals Expands Its Integrated And Outsourced Solutions; Sandra Gardiner Succeeds Rex Merchant As Acting Chief Financial Officer
Benzinga · 03/08 13:19
Anebulo Pharmaceuticals Appoints Sandra Gardiner as Acting Chief Financial Officer
Anebulo Pharmaceuticals Appoints Sandra Gardiner as Acting Chief Financial Officer
MT Newswires · 03/08 11:39
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 03/07 18:02
Benchmark Maintains Speculative Buy on Anebulo Pharmaceuticals, Lowers Price Target to $8
Benzinga · 02/14 13:28
--Benchmark Adjusts Anebulo Pharmaceuticals' Price Target to $8 From $10, Keeps Speculative Buy Rating
--Benchmark Adjusts Anebulo Pharmaceuticals' Price Target to $8 From $10, Keeps Speculative Buy Rating
MT Newswires · 02/14 10:47
More
About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The Company’s lead product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, to address the unmet medical need for a specific antidote for ACI. ANEB-001, is intended to rapidly reverse the negative effects of ACI within one hour of administration. The signs and symptoms of ACI range from profound sedation to anxiety and panic to psychosis with hallucinations. CB1 receptors are concentrated in the brain and central nervous system, while CB2 receptors are found mostly in peripheral organs and are associated with the immune system.

Webull offers kinds of Anebulo Pharmaceuticals Inc stock information, including NASDAQ:ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.